IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

ATLM DIAGNOSTICS AND THERAPEUTICS LLP

LLPIN : ACO-0659|ROC: RoC-PatnaActive
Last Updated On : 11-09-2025
LLPINACO-0659
LLP NameATLM DIAGNOSTICS AND THERAPEUTICS LLP
Number of Partners3
Number of Designated Partners3
ROC CodeRoC-Patna
Date of Incorporation02-05-2025
Registered AddressCo-Smt. Manju Devi Padri Ki Haweli Ward No59 Patna City Patna Sampatchak Bihar India 800008
Email IDniraj_doc06@yahoo.co.in
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India86
Description of main divisionHUMAN HEALTH ACTIVITIES
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
10027879NIRAJ KUMAR02-05-2025
11087468MAMTA SINGH02-05-2025
11087467AMIT ANAND02-05-2025
ATLM DIAGNOSTICS AND THERAPEUTICS LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Patna, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 02-05-2025 and last updated on 11-09-2025. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, ATLM DIAGNOSTICS AND THERAPEUTICS LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is Co-Smt. Manju Devi Padri Ki Haweli Ward No59 Patna City Patna Sampatchak Bihar India 800008. Correspondence or inquiries may be sent to the official email address, niraj_doc06@yahoo.co.in.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.